Actively Recruiting
Long-Term Observation Study of Early-Stage Invasive Breast Cancer Patients Previously in GEICAM Clinical Trials
Led by Spanish Breast Cancer Research Group · Updated on 2026-10-13
8000
Participants Needed
73
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a multicenter observational study to gather long-term information from patients diagnosed with early-stage invasive breast cancer. These patients have previously participated in neoadjuvant or adjuvant clinical trials conducted by the GEICAM group. The study aims to provide data on the long-term outcomes and sequelae related to breast cancer treatments beyond the original trial follow-up periods. Participants are included after completing follow-up in their original GEICAM clinical trials and will be observed for approximately 30 years. This extended observation allows for evaluation of event-free survival and disease-free survival over a long duration. The study collects ongoing data without providing additional interventions. During the study, participants will be monitored through data collection related to survival outcomes, including overall survival, event-free survival, and disease-free survival. This long-term follow-up provides valuable information for healthcare professionals, patients, and society regarding the evolution and management of early-stage invasive breast cancer. Participation involves no new treatment, only data collection over many years.
CONDITIONS
Brief Title
Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies
Research Team
S
Study Project Manager
S
Start-Up Unit Manager
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here